Patent · US Active

Mutations of the parkin gene, compositions, methods and uses

US9540693B2 · kind B2 · utility

0Cited by

4References

18Claims

0Family size

Assignees

AVENTIS PHARMA S.A. · FR
Institut National de la Sante et de la Recherche Medicale (INSERM) · FR

Inventors

Alexis Brice · Paris, FR
Christophe Lucking · Paris, FR
Patrice Denefle · Châteauroux, FR
Sylvain Ricard · Paris, FR
Nacer Eddine Abbas · Paris, FR
Sandrine Bouley · Lons-le-Saunier, FR

Key dates

Filing date	Aug 7, 2014
Grant date	Jan 10, 2017
Priority date	—
Expiry date	Aug 7, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y603/02019
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention concerns nucleic acids coding for mutated or truncated forms of the human parkin gene, or forms comprising multiplication of exons, and the corresponding proteins and antibodies. The invention also concerns methods and kits for identifying mutations of the parkin gene, and for studying compounds for therapeutic purposes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.